Livermore Lab to Develop Nanostring-based Biothreat Dx Tests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Lawrence Livermore National Laboratory has landed a $2.4 million grant to work with university partners to develop biodefense-focused pathogen tests based on a platform from NanoString Technologies, LLNL said today.

The aim of the project funded by the National Institutes of Health's Partnerships for Biodefense program, is to develop assays for detecting a wide range of viral pathogens that could be used as bioweapons or which could arise unintentionally.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.